Adherence to long-term therapy in cardiovascular patients with atrial fibrillation
prev
next
prev
next
Author(s)
Author(s)
Adherence to long-term therapy in cardiovascular patients with atrial fibrillation Elena Konobeeva
Atrial fibrillation is one of the most common diseases, often a complication of other diseases.
Atrial fibrillation occurs in about 1-2% of cases in the entire population, the number of such patients is increasing, among them a significant number of patients of young working age who lead a socially active life. In accordance with the structure of mortality, the death rate from strokes is very significant, and one of the main causes of stroke is the presence of atrial fibrillation in the patient. The incidence of strokes in patients of any etiology with atrial fibrillation is 5% per year.
More than 40% of patients with severe chronic heart failure also have atrial fibrillation.
Therefore, adequate hypotensive, antiarrhythmic, anticoagulant therapy, as well as compliance with medical recommendations on lifestyle and treatment of concomitant conditions is a necessary condition for improving the quality and duration of life.
Given that non-compliance of patients with coronary heart disease and atrial fibrillation
leads to more frequent hospitalizations and a worse prognosis and the development of additional risks of cardiovascular events, it is important to study the impact of individual clinical factors on improving adherence to long-term therapy.
The study included 116 subjects (56 – Test arm and 60 – Control arm). The Test arm included subjects with persistent and permanent atrial fibrillation; the Control arm consisted of subjects with sinus rhythm. The study objective was to evaluate the features of adherence to long-term therapy in patients with atrial fibrillation and no evidence of cognitive impairment.
DOI: https://ysmu.am/v2/wp-content/uploads/2023/09/10-ad.pdf The New Armenian Medical Journal Vol.14 (2020), Nо 2 79-83
